<p>An siRNA for osteopontin that is useful as a medicine for the treatment of diseases attributed to an accentuation of osteopontin; and a method of screening with the use thereof. There are provided an siRNA for osteopontin; a composition and medicine comprising the same; and a method of screening a substance capable of interacting with osteopontin or a substance capable of inhibiting or inhibiting or promoting the interaction.</p>
